A recent international study analysed over 9000 participants across 37 studies to understand the long-term effects of weight-loss medications, including GLP-1 receptor agonists. The findings show that...
Alcidion, an Australian digital health company, has been chosen as the preferred supplier for a new electronic patient record system at University Hospitals Sussex NHS Foundation Trust in the UK. The...
Health Minister Mark Butler is moving to expand PBS access to GLP-1 drugs like Wegovy for obesity treatment. Currently, these medications are only subsidised for type 2 diabetes. The government is con...
Australian research organisations Orygen and the University of Melbourne have secured $14 million in funding from Wellcome to expand their digital mental health platform, MOST-Nexus. This platform bui...
The Australian Department of Health is planning to expand GP access to certain MRI scans in three phases. The first phase would allow GPs to request rebates for specific MRIs, including those for the...
A new study in Lancet Psychiatry compares different strategies for stopping antidepressants. It looked at sudden stopping, fast tapering, slow tapering, dose reduction, and continuing treatment. The r...
The Department of Health, Disability and Ageing (DoHDA) is reviewing proposals to expand bulk-billed MRI access for GPs. The plan aims to allow GPs to request MRI scans for more conditions, starting w...
AI scribes are becoming more common in Australian healthcare, with nearly 40% of GPs using them regularly. They can save time on documentation but come with legal risks. Practitioners must get patient...
Hyaluronic acid injections for knee osteoarthritis are under renewed scrutiny. Hospitals report an increase in serious infections linked to these injections. Experts say the injections do not provide...
In 2025, GLP-1 receptor agonists remained a major focus in healthtech, showing benefits like reduced heart failure risk, weight loss, and better blood sugar control. However, concerns about side effec...
Researchers studied over 19,000 US primary care patients with uncontrolled hypertension in 2021. They found that simply improving medication adherence or increasing medication doses did not significan...
Professor Candid highlights the daily struggles faced by GPs in Australia. He points out how GPs deal with complex paperwork like NDIS forms and managing patient expectations. Many patients forget imp...
The first randomised trial in Australia tested how women react to being told about their breast density after mammograms. About 2,400 women aged around 57 were split into three groups: one received no...
Antidepressant use in Australia has increased significantly over the past decade. More people are staying on medication beyond the recommended 12 months. In 2014, there were about 135,000 long-term us...
A new position paper from the World Association of Sarcoidosis and Other Granulomatous Disorders challenges the long-standing use of corticosteroids as the first treatment for sarcoidosis. It argues t...
Long-term antidepressant use in Australia has increased over the past decade, especially among young people aged 10 to 24. The number of young Australians on antidepressants for more than a year rose...
Research shows female GPs in Australia earn about $24 less per hour than male GPs. The study analysed Medicare billings from 511 GPs across five states and territories. Female GPs bill nearly $40,000...
The Australian Government released its National AI Plan this week. It aims to build an AI-enabled economy and promote AI in sectors like healthcare. The plan focuses on attracting investment, spreadin...
The Australian government declared syphilis a disease of national significance in 2025, with over 3500 cases reported this year. Congenital syphilis has caused several infant deaths, highlighting the...
Western Sydney is experiencing rapid population growth, expected to reach 6 million by 2041. This increase drives a higher demand for cardiovascular imaging and other radiology services. The region fa...
